---
title: "Pharma Pulse 2/5/25: What Do Real Patients Actually Talk About? ADHD Stimulant Dispensing Decreased Over Past Decade & more"
date: "2025-02-05 19:00:00"
summary: "SCOPE Summit 2025 Opening Keynote Panel: What Do Real Patients Actually Talk About?Interactive panel on day 1 of SCOPE Summit 2025 highlighted the need for inclusive narratives, social listening to understand patient experiences, and the role of advocacy groups in opening doors to clinical trials.ADHD Stimulant Dispensing Decreased Over the..."
categories:
  - "pharmexec"
lang:
  - "en"
translations:
  - "en"
tags:
  - "pharmexec"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

[**SCOPE Summit 2025 Opening Keynote Panel: What Do Real Patients Actually Talk About?**](https://www.appliedclinicaltrialsonline.com/view/scope-summit-2025-opening-keynote-panel-real-patients)

Interactive panel on day 1 of SCOPE Summit 2025 highlighted the need for inclusive narratives, social listening to understand patient experiences, and the role of advocacy groups in opening doors to clinical trials.

[**ADHD Stimulant Dispensing Decreased Over the Past Decade, Study Finds**](https://www.pharmacytimes.com/view/adhd-stimulant-dispensing-decreased-over-the-past-decade-study-finds)

Prescription stimulant dispensing was greatly impacted by the COVID-19 pandemic and drug shortages.

[**Merck Halts China Gardasil Shipments, Boosting Investor Concern**](https://www.bloomberg.com/news/articles/2025-02-04/merck-halts-gardasil-sales-in-china-dragging-on-2025-outlook)

Merck & Co. shares tumbled after the company halted shipments to China of its cancer-preventing Gardasil vaccine, a dramatic escalation to the company’s problems in the country that threatens the future of a blockbuster product.

[**Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO**](https://www.businesswire.com/news/home/20250204112044/en)

Thermo Fisher Scientific Inc. announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO designed to increase access to renewable electricity across the pharmaceutical and healthcare supply chains. The Lorca solar project is expected to be operational in early 2026 and includes a cohort of three partners from the pharmaceutical and healthcare sectors.

[**Adam Shapiro on LinkedIn**](https://www.linkedin.com/feed/update/urn:li:activity:7290768287536173056?commentUrn=urn%3Ali%3Acomment%3A%28activity%3A7290768287536173056%2C7291049786797867009%29&dashCommentUrn=urn%3Ali%3Afsd_comment%3A%287291049786797867009%2Curn%3Ali%3Aactivity%3A7290768287536173056%29)

Empowering reps with AI means better results for everyone.

*Have news you want us to share in Pharma Pulse? Reach out to Editor [Miranda Schmalfuhs](mailto:mschmalfuhs@mjhlifesciences.com)*

[pharmexec](https://www.pharmexec.com/view/pharma-pulse-2-5-25-)
